These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis of dibenzodioxazocines and their effects on cholinesterases and muscarinic cholinergic receptors. Gaál J; Batke J; Borsodi A; Rózsa L; Somogyi G Acta Biochim Biophys Hung; 1989; 24(1-2):129-42. PubMed ID: 2514534 [TBL] [Abstract][Full Text] [Related]
3. [Structure-activity relationship in the series of muscarinic acetylcholine receptor agonists: three types of agonist-receptor complexes]. Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS Bioorg Khim; 1985 Oct; 11(10):1391-401. PubMed ID: 4074399 [TBL] [Abstract][Full Text] [Related]
4. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity. Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545 [TBL] [Abstract][Full Text] [Related]
5. [Structure-activity relationship in the series of muscarinic acetylcholine receptor antagonists: four types of antagonist-receptor binding]. Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS Bioorg Khim; 1985 Oct; 11(10):1402-16. PubMed ID: 4074400 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines. Loew GH; Lawson JA; Uyeno ET; Toll L; Frenking G; Polgar W; Ma LY; Camerman N; Camerman A Mol Pharmacol; 1988 Sep; 34(3):363-76. PubMed ID: 2843751 [TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509. Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498 [TBL] [Abstract][Full Text] [Related]
8. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships. Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246 [TBL] [Abstract][Full Text] [Related]
10. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Spivak CE; Waters JA; Aronstam RS Mol Pharmacol; 1989 Jul; 36(1):177-84. PubMed ID: 2747625 [TBL] [Abstract][Full Text] [Related]
11. Conformational change of ascidiacyclamide caused by asymmetric modification for an isoleucine residue: structural analyses of [Gly], [Leu], and [Phe]ascidiacyclamides by x-ray diffraction and NMR spectroscopy. Doi M; Shinozaki F; In Y; Ishida T; Yamamoto D; Kamigauchi M; Sugiura M; Hamada Y; Kohda K; Shioiri T Biopolymers; 1999 May; 49(6):459-69. PubMed ID: 10193193 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity. Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458 [TBL] [Abstract][Full Text] [Related]
14. 1H NMR study of the conformation and absolute stereochemistry of two spirocyclic NK-1 antagonists. Herbert RH; Gerhard U; Mortishire-Smith RJ; Thomas SR; Hollingworth G Magn Reson Chem; 2005 Aug; 43(8):658-61. PubMed ID: 15924294 [TBL] [Abstract][Full Text] [Related]
15. Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships. Bang-Andersen B; Lenz SM; Skjaerbaek N; Søby KK; Hansen HO; Ebert B; Bøgesø KP; Krogsgaard-Larsen P J Med Chem; 1997 Aug; 40(18):2831-42. PubMed ID: 9288165 [TBL] [Abstract][Full Text] [Related]
16. Conformation analysis of aspartame-based sweeteners by NMR spectroscopy, molecular dynamics simulations, and X-ray diffraction studies. De Capua A; Goodman M; Amino Y; Saviano M; Benedetti E Chembiochem; 2006 Feb; 7(2):377-87. PubMed ID: 16372303 [TBL] [Abstract][Full Text] [Related]
17. Molecular requirements for antimuscarinic activity in 1,3-oxathiolanes. Angeli P; Bacchiocchi D; Giannella M; Pigini M; Romanelli MN Drug Des Deliv; 1988 May; 2(4):263-72. PubMed ID: 3255319 [TBL] [Abstract][Full Text] [Related]
18. Change in the reactivity of the active-site serine OH of butyrylcholinesterase caused by a new reversible inhibitor. Gaál J; Bartha F; Batke J Eur J Biochem; 1983 Sep; 135(1):157-62. PubMed ID: 6884355 [TBL] [Abstract][Full Text] [Related]
19. Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models. Högberg T; Rämsby S; de Paulis T; Stensland B; Csöregh I; Wägner A Mol Pharmacol; 1986 Oct; 30(4):345-51. PubMed ID: 2945089 [TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane. Galper JB; Haigh LS; Hart AC; O'Hara DS; Livingston DJ Mol Pharmacol; 1987 Aug; 32(1):230-40. PubMed ID: 3112557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]